Castle Biosciences, Inc. · 23 hours ago
Reimbursement, Customer Service Specialist
United States
Full-time
Remote
Mid Level
3+ years expCastle Biosciences Inc. is a growing company recognized as a top workplace, seeking a full-time Customer Service Specialist. This role is responsible for managing communication and inquiries related to insurance billing, providing support and education to various stakeholders.
BiotechnologyHealth CareHealth Diagnostics
No H1B
Responsibilities
Answering incoming calls and email inquiries from patients, clinicians, insurance plans, and area sales managers
Provides support for insurance billing-related questions
Educates callers on reimbursement processes, billing policies, and required documentation needed for appeals and medical record submissions
Managing inbound communications
Ensuring timely, accurate responses
Delivering clear guidance to a wide range of internal and external stakeholders
Qualification
Required
Minimum of three years of customer service experience, preferably in a call center environment
Minimum of two years of health insurance billing with experience in identifying and resolving claim issues
Experience collaborating with patients, providers, and insurance plans throughout the billing cycle
Experience researching and utilizing payor websites
Certification in Medical Billing and/or Coding or equivalent experience
Must demonstrate the ability to type 35 WPM with 90% or higher accuracy
All candidates must be legally authorized to work in the United States
Benefits
20 Accrued PTO Days Annually + 10 Paid Holidays
401K with 100% Company Match up to 6%
3 Health Care Plan Options + Company HSA Contribution
Company Stock Grant Upon Hire
Company
Castle Biosciences, Inc.
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$427.33MKey Investors
BrightEdge FundIndustry VenturesHealthQuest Capital
2020-12-15Post Ipo Equity· $266.8M
2020-06-24Post Ipo Equity· $74M
2019-07-24Series Unknown
Leadership Team
Derek Maetzold
President, CEO and Founder
Recent News
GlobeNewswire
2026-01-12
Company data provided by crunchbase